Company Overview#
Ainex Corporation is a medical AI software company specializing in gastrointestinal endoscopy. The company is dedicated to developing AI technology that enhances clinicians’ diagnostic accuracy and ultimately saves patients’ lives. Its flagship product, ENAD, integrates seamlessly into the endoscopy workflow to detect abnormal lesions in real time and provide actionable diagnostic insights.
Technology & Product#
The core product is ENAD, an AI-assisted diagnostic software for both upper and lower gastrointestinal endoscopy. The system operates on existing endoscopy monitors without requiring specialized hardware, linking via a simple connection module. For lower GI procedures, ENAD CADe detects colon polyps in real time, while ENAD CADx categorizes the detected polyps into adenoma/neoplasm, hyperplastic polyp, or sessile serrated lesion.
Market & Use Cases#
Ainex targets gastroenterologists and internal medicine departments conducting routine endoscopic screenings. By deploying ENAD, hospitals can improve the detection rates of hard-to-spot polyps and adenomas, reducing the risk of missed diagnoses during high-volume endoscopy sessions.
Traction & References#
ENAD has been adopted by more than 130 hospitals in Korea and over 30 global institutions. The software demonstrates robust clinical performance, improving the adenoma detection rate by 16.2%p with ENAD CADe. ENAD CADx classifies detected polyps — adenoma/neoplasm, hyperplastic polyp, or sessile serrated lesion — with over 90% accuracy. ENAD CADx has obtained Class III medical device approval from the MFDS in Korea and passed the Innovative Medical Device integrated review in 2025, and was designated an innovative product by Korea’s Public Procurement Service (PPS) in April 2026. The product has also been approved and commercialized in seven countries, including Thailand, Singapore, and Vietnam. In January 2026, Ainex signed an MOU with Olympus Korea to expand ENAD’s domestic business(Ainex Press).
Collaboration Relevance#
Ainex is well-positioned for distribution and integration partnerships with global endoscopy equipment manufacturers (such as Olympus, Pentax, or Fujifilm). The company is also a strong candidate for collaborative research with global medical institutions seeking to implement and validate AI-assisted endoscopy diagnostics in diverse patient populations.